Metcalfe JZ, Weir IR, Scarsi KK, Mendoza-Ticona A, et al. A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial. Lancet Infect Dis 2025 Sep 4:S1473-3099(25)00436.
PMID: 40915311